Top

HomeIPSFeedbackSubscribe cited Login

articles
UsersOnline:422

Aheadof
About CurrentIssue Archive Search Instructions Announcements Etcetera Contact Advertise
print

Search

Search

SimilarinPUBMED
SearchPubmedfor
RESEARCHARTICLE
MinazN
RazdanR Year:2016|Volume:48|Issue:5|Page:544549

SearchinGoogleScholar
for Therapeuticinsightintomolsidomine,anitricoxidedonorinstreptozotocininduceddiabetic
nephropathyinrats
MinazN
RazdanR NathaniMinaz,RemaRazdan
DepartmentofPharmacology,AlAmeenCollegeofPharmacy,Bengaluru560027,
Relatedarticles Karnataka,India

Albuminuria
molsidomine DateofSubmission 03Jun2016
nitricoxide 04Aug
oxidativestress DateofAcceptance
2016
DateofWeb
16Sep2016
ArticleinPDF(1,666KB) Publication
CitationManager
AccessStatistics CorrespondenceAddress:
NathaniMinaz
ReaderComments
DepartmentofPharmacology,AlAmeenCollegeofPharmacy,Bengaluru560027,
EmailAlert* Karnataka
AddtoMyList* India
*Registrationrequired(free)

SourceofSupport:None,ConflictofInterest:None

Abstract
MaterialsandMe... DOI:10.4103/02537613.190744
Results
Discussion
Conclusion
References Abstract
ArticleFigures
ArticleTables Background:Diabetesinducedoxidativestressandhypertensionplayamajorroleinthe
developmentofnephropathy.Hence,thepresentstudywasundertakentoevaluatethe
ArticleAccessStatistics protectiveeffectsofmolsidomine,anitricoxidedonorinstreptozotocin(STZ)induced
diabeticnephropathy(DN)inrats.
Viewed 386 MaterialsandMethods:Type1diabeteswasinducedthroughasingledoseofSTZ(52
Printed 1 mg/kg,i.p.)inmaleWistarratsandthentreatedwithmolsidomine(5and10mg/kgp.o.)for8
Emailed 0 weeks.Physicalparameters,vitalandrenalfunctiontestincludingbloodglucose,albuminuria,
PDFDownloaded 64 bloodurinenitrogen,serumcreatinine,andkidneyindexweredetermined.Oxidativestress
Comments [Add] andlipidperoxidationwereassessedinthekidneyhomogenatebymeansofantioxidant
enzymesandmalondialdehydelevels.
Results:DNratsexhibitedasignificantrenaldysfunctionwithareductioninbodyweight,
excessiveoxidativestress,andpathologicalchanges.Molsidominetreatmentsignificantly
improvedvitalsign,renalfunctions,andoxidativestressinDNratsinadosedependent
manner.Theprotectiveeffectofmolsidominewasalsosubstantiatedbypathologicalchanges

inthearchitectofthekidney.
Conclusion:MolsidomineshowsasignificantbeneficialeffectinType1DNinrats.

Keywords:Albuminuria,molsidomine,nitricoxide,oxidativestress

Howtocitethisarticle:
MinazN,RazdanR.Therapeuticinsightintomolsidomine,anitricoxidedonorin
streptozotocininduceddiabeticnephropathyinrats.IndianJPharmacol201648:5449

HowtocitethisURL:
MinazN,RazdanR.Therapeuticinsightintomolsidomine,anitricoxidedonorin
streptozotocininduceddiabeticnephropathyinrats.IndianJPharmacol[serialonline]2016
[cited2016Dec8]48:5449.Availablefrom:http://www.ijponline.com/text.asp?
2016/48/5/544/190744

Diabetesrelatedmorbidityandmortalityareaccountedforitscomplicationssuchas
nephropathy,neuropathy,andretinopathy.Chronichyperglycemiaistherootcauseforunique
changesinrenalstructure.Itisoneoftheleadingcausesofendstagerenaldisease.
Approximately,40%ofdiabeticpatientsdiagnosedwithnephropathyeitherrequirekidney
dialysisortransplantation.Diabeticnephropathy(DN)ischaracterizedbymicroalbuminuria,
renalhypertrophy,andmesangialexpansionwithglomerularbasementmembranethickening.
[1]Hypertension,smoking,anddyslipidemiaarethemajorcontributorsfortheprogressionof
nephropathy.AspertheUKProspectiveDiabetesStudy,tightcontrolonsystolicblood
pressure(SBP)lessenedtheriskforthedevelopmentofmicroalbuminuria.[2]

Streptozotocin(STZ)destroysthebetacellsofthepancreaswhichleadstohyperglycemia.
Themechanismforitscellinjuryisassociatedwiththegenerationofreactiveoxygenspecies
(ROS)andoxidativestress.[3]AnSTZinducedrodentmodelofType1diabetesdevelops
renalinjurywhichresemblestohumanDN.[4]Itisavaluableandbroadlyacceptedmodelfor
interpretationoftherapeuticinterventionsinpreclinicaldiabeticrenalinjury.

Nitricoxide(NO),apotentendogenousvasodilator,hasaroleinmaintainingsystemicblood
pressureandrenalfunctions.BasalproductionofNOiscrucialfortheroutineglomerular
functions.[5]Itsbioactivityisreducedbysuperoxide,amajorROS.[6]Reductionof
antioxidantenzymesindiabetesresultsinoverproductionofROSwhichconvertsNOinto
peroxynitriteandproducesnitrosativestress.Iqbaletal.haveshownthatexogenousNOdonor
administration,preventstheoxidativestress,andrestorestherenalfunctions.[7]

Molsidomine,anNOdonor,hasantioxidantandvasodilatoreffects.Itisusedforthetreatment
ofstableangina.Molsidominerelaxesvascularsmoothmusclebystimulatingguanylate
cyclase.[8]ThepurposeofthepresentstudywastoinvestigatewhetherNOdonorcan
attenuateDNinSTZinduceddiabeticrats.

MaterialsandMethods

ChemicalsandReagents

MolsidominewasprocuredasagiftsamplefromTajPharmaceutical,Mumbai,withquality
controlreport.STZwaspurchasedfromtheMPBiomedicalIndiaPvt.Ltd.Thekitsusedfor
biochemicalanalysiswereprocuredfromtheAutospandiagnostic,Surat,India.Other
chemicalsandreagentsusedwereofanalyticalgrade.

Animals

Healthyweightmatched(250300g)maleWistarratswereselectedandhousedin
polypropylenecageslayeredwithhuskandkeptfor12hlight/12hindarkcyclewithfree
accesstowaterandstandardpelletdiet.Theuseofexperimentalanimalswasapprovedbythe
InstitutionalAnimalEthicalCommitteeofAlAmeenCollegeofPharmacy(ApprovalNo:
AACP/IAEC/Aug2014/01).TheexperimentwasconductedaccordingtotheCPCSEA
guidelines.

InductionofDiabetesandExperimentalDesign
InductionofDiabetesandExperimentalDesign

Type1diabeteswasinducedbyasingleintraperitonealinjectionofSTZ(52mg/kg)infreshly
preparedcitratebuffer(0.1M,pH4.5).[9]Ratsweregiven5%w/vglucosesolutionfor48h
topreventhypoglycemiainducedmortality.Aweeklater,theratswithfastingbloodglucose
(FBG)values230mg/dLwereconsideredtobediabeticandusedinthestudy.Total24
Wistarratswererandomlydividedintofourgroupsofsixanimalseach.

GroupIservedasnormalcontrol.
GroupIIservedasDNcontrol.
GroupIIIandIVservedasatestgroup,(diabeticratswereadministeredmolsidomine[5
and10mg/kg,p.o.]for8weeks).

Dosesofmolsidominewerechosenbasedonthepreviousstudyinwhichithasshownthe
nephroprotectiveeffectanddidnotproduceanysideeffects.[10]

MeasurementofPhysicalParameter

Theanimalsweremonitoredforphysicalparameterssuchasbodyweight(BW),weakness,
andmortalitythroughoutthestudy.BWwasmeasuredbeforeinductionofdiabetesandatthe
8thweekusingdigitalbalance(EssaeDS252).Percentagechangewascalculatedfromthe
BWofbeginningandattheendofthestudy.

MeasurementofVitalSigns

ProgressionofDNisstronglyassociatedwithhypertension.Hence,SBPwasmeasuredatthe
8thweekofthestudybytailcuffmethod.[11],[12]Eachmeasurementwasrepeated56times
andvalues,notdifferentbymorethan3mmHg,wereconsideredvalid.Themeanofthethree
measurementswasthenrecordedandreportedasthevalueofSBPforeachanimal.

MeasurementofRenalFunction

Onthe8thweek,anindividualratfromeachgroupwasplacedinmetaboliccagesfor24hto
collecturinewithfreeaccesstofoodandwaterurinevolume(ml/24h)wasmeasured.
Urinaryalbuminlevelsweredetectedusingassaykitsbyautoanalyzeraccordingtothemanual
providedbythemanufacturer.Urinaryalbuminexcretionrate(UAER),anindicationof
albuminuria,wascalculatedbytheformula,UAER(mg/24h)=24hurinevolumeurinary
albumin(mg/dl).Overnightfastedanimalswereanesthetizedbloodwaswithdrawnthrough
retroorbitalandcollectedinclotactivatorVacutainerthencentrifugedat3000RPMfor10
mintoseparatetheserum.FBG,bloodurinenitrogen,andserumcreatinine(Scr)were
determinedbyautoanalyzer.Allkitswereusedinaccordancewithmanufacturerinstructions.
Then,animalsweresacrificed,andtheirkidneyswereisolatedandweighed.Thekidneyindex
wascalculatedas100kidneyweight/BW.Rightkidneyswereusedforhomogenate
preparationandleftkidneyswerestoredinformalinforhistopathologystudy.

MeasurementofOxidativeStress

Kidneyswerewashedwithsaline,choppedonice,andhomogenate(10%,w/v)wasprepared
with0.1Mphosphatebufferandcentrifugedat3000gfor10minat4CusingSorvall
refrigeratedcentrifugeandsupernatantwasusedforbiochemicalestimations.

Lipidperoxidationormalondialdehyde(MDA)formationwasdeterminedbythemethodof
SlaterandSawyer.[13]Catalase(CAT)activitywasdetectedbythemethodofAebi's
description[14]andglutathione(GSH)wasdeterminedbythemethodofMoronetal.[15]
superoxidedismutase(SOD)wasdeterminedbythemethodofMisraandFridovich.[16]

Histopathology

Paraffinembeddedspecimenswerecutinto5mthicksectionsandstainedwithhematoxylin
andeosin.Thesectionswereexaminedunderalightmicroscopeforthepresenceof
pathologicalchangesandphotomicrographsweretaken.Thepathologistwasblindedtothe
animaltreatmentgroup.

StatisticalAnalysis
Valuesareexpressedasmeanstandarderrorofmean(SEM).Statisticalsignificancewith
respecttoDNcontrolwasevaluatedusingonewayANOVAfollowedbyTukey'sttestusing
GraphPadPrismsoftware(Version5.0,GraphPadPrismSoftwareInc.,SanDiego,CA).

Results

EffectofMolsidomineonPhysicalParameter

Inthepresentstudy,therewasacontinuousreductioninBWofDNratsthroughoutthestudy,
whiletherewasagainintheBWofnormalrats.Atthe8thweek,thepercentagechangein
BWofdiabeticandnormalratswas53.28and3.97,respectively.Treatmentwith
molsidominesignificantly(P<0.001)preventedthepercentagechangeinBWdose
dependentlycomparedtodiabeticrats.MolsidominepreventedthediabeticratsfromvastBW
loss[Table1].
Table1:Effectofmolsidomineoninbodyweight,kidney
index,andrenalfunctionrelatedparametersinrats

Clickheretoview

EffectofMolsidomineonVitalFunction

Atthe8thweek,SBPofDNratswas30mmHghigherthanthatofthenormalcontrolrats.
Molsidominetreatedratssignificantly(P<0.001)reducedtheelevatedbloodpressurelevel
dosedependentlycomparedtodiabeticrats[Figure1].
Figure1:Effectofmolsidomineonsystolicbloodpressure
(mmHg)inrats.NCNormalcontrol,DNC=Diabetic
nephropathycontrol,MOL5=Molsidomine(5mg/kg),
MOL10=Molsidomine(10mg/kg).Valuesarerepresented
asmeanstandarderrorofthemean(n=6).***P<0.001
versusdiabeticnephropathycontrolgroup

Clickheretoview

EffectofMolsidomineonRenalFunctions

TheFBGlevelintheDNcontrolratswas330mg/dL,nearly3timeshighercomparedto
normalcontrolrats.Bycontrast,molsidominetreatedratssignificantlydecreasedtheelevated
fastingserumglucoselevel(P<0.001)comparedtodiabeticrats[Figure2].
Figure2:Effectofmolsidomine(5and10mg/kg,p.o.)on
fastingbloodglucoselevelinrats.(mg/dl).NC=Normal
control,DNC=Diabeticnephropathycontrol,MOL5=
Molsidomine(5mg/kg),MOL10=Molsidomine(10mg/kg).
Valuesarerepresentedasmeanstandarderrorofthemean
(n=6).**P<0.01,***P<0.001versusdiabetic
nephropathycontrolgroup

Clickheretoview

InDNrats,allmentionedrenalparametersweresignificantly(P<0.001)increasedcompared
tonormalcontrolrats,showingthatdiabeticratswereprogressingtonephropathy.Asdepicted
in[Table1],treatmentwithmolsidominepreventeddiabetesinducedrenalabnormality
comparedtodiabeticcontrolratsindosedependentmannerbypreservingitsnormal
functions.

EffectofMolsidomineonOxidativeStressandLipidPeroxidation

DNcontrolratsexhibitedasignificant(P<0.001)decreaseinSOD,reducedglutathioneand
CATactivity[Figure3]comparedtonormalcontrolrats.
Figure3:Effectofmolsidomineonrenalantioxidant
enzymesinrats.NC=Normalcontrol,DNC=Diabetic
 enzymesinrats.NC=Normalcontrol,DNC=Diabetic
nephropathycontrol,MOL5=Molsidomine(5mg/kg),
MOL10=Molsidomine(10mg/kg).Valuesarerepresented
asmeanstandarderrorofthemean(n=6).***P<0.001
versusdiabeticnephropathycontrolgroup

Clickheretoview

TheMDAlevelwhichistheendproductoflipidperoxidationwasincreasedsignificantlyin
kidneyhomogenateofdiabeticrats(P<0.001)whencomparedtonormalcontrolrats.
MolsidominetreatedratssignificantlyreducedMDAlevelindosedependentmanner
comparedtoDNrats[Figure4].
Figure4:Effectofmolsidomineonrenalmalondialdehyde
(M/mgprotein).NC=Normalcontrol,DNC=Diabetic
nephropathycontrol,MOL5=Molsidomine(5mg/kg),
MOL10=Molsidomine(10mg/kg).Valuesarerepresented
asmeanstandarderrorofthemean(n=6).***P<0.001
versusdiabeticnephropathycontrolgroup

Clickheretoview

EffectofMolsidomineonRenalPathologicalChanges

Thehistopathologicalexaminationofkidneytissueofnormalratsshowedthenormal
appearance.RenaltissuesectionofDNcontrolratsshowedglomerulosclerosis,tubular
degeneration,mononuclearcell(MNC)infiltration,andthickeningofglomerularbasement
membrane.ThetreatmentwithMol5showedamoderateglomerularnecrosisandMNC
infiltration.However,thetreatmentwithMol10showednoabnormalityandthearchitectof
kidneytissueappearednormal[Figure5]ad.
Figure5:Histopathologyofkidneytissueofnormalcontrol,
diabeticnephropathycontrol,andtreatedgroupsrats.(a)
Sectionofnormalratkidneytissueshowingnormal
appearanceofglomerulusandtubules.(b)Sectionofdiabetic
ratkidneytissueshowingglomerulosclerosis,tubular
degeneration,andmononuclearcellinfiltration.(c)Section
ofdiabeticratkidneytissuetreatedwithmol5mg/kg
showingmoderateglomerularnecrosisandmononuclearcell
infiltration.(d)Sectionofdiabeticratkidneytissuetreated
withmol10mg/kgshowingnoabnormality(10)

Clickheretoview

Discussion

DNisoneoftheleadingcausesofmorbidityandmortalityindiabeticpatientsglobally.
PreventingtheprogressionofDNhasbeenachallengeinbiomedicalresearch.Hypertensionis
ariskfactorforprogressionofDN.Reductionofbloodpressureisbeneficialinpreventing
progressionofDN.Onotherhand,manystudieshaveshownthatoxidativestressplaysa
majorroleinthedevelopmentdiabeticrenalinjuries.Molsidomine(NOdonor)has
antioxidativeandvasodilatoreffects.Hence,thepresentstudywasundertakentoevaluatethe
effectsofmolsidomineinDN.

STZinduceddiabeticratsaremoreliabletodevelophypertension.[17]Elevatedblood
pressurehasadamagingeffectonkidney.Inthepresentstudy,theSBPwassignificantly
higher(P<0.001)inDNgroupcomparedtothenormalgroup,andthisrisewaspreventedby
molsidominetreatment.Theantihypertensiveeffectofmolsidomineisthemajorintervention
inthepreventionofalbuminuriawhichisduetoitsvasodilatationeffect.

Microalbuminuria(definedasUAER30300mg/day)isconsideredapredictorofworse
outcomesforbothkidneyandheartpatients.[18]Highbloodpressuremaycause
microalbuminuriabyincreasingglomerularfiltrationpressureandsubsequentrenaldamage.
Thefindingsofourstudyrevealedthattreatmentwithmolsidominehassignificantlyprevented
Thefindingsofourstudyrevealedthattreatmentwithmolsidominehassignificantlyprevented
microalbuminuriainthediabeticgroup.

InsulindeficiencyinType1diabetespreventstheentryofglucoseintothecells.Asaresult,
cellsstartstarvationandlossofBWoccurs.BWwasobservedinconcurrencewiththe
continuationofdiabetesinthestudy.MolsidominetreatmentpreventedmassivelossofBW.

Severalstudieshaveshownthatmultiplefactorscausedbyhyperglycemiaplayaroleinthe
developmentofdiabetickidneydisease.Thehyperglycemicconditionresultsinirreversible
tissuedamagethroughtheproteinglycationreactionthatleadstotheformationof
glycosylatedproteinandadvancedglycationendproduct.[19],[20]Inthepresentstudy,
molsidominehaspreventedthehyperglycemiaofdiabeticratswhichshowsitsrolein
nephroprotection.

Inourstudy,STZinduceddiabeticratssuccessfullydevelopedDNwhichwasevidencedby
polyurea,albuminuria,andincreasedinmetabolicwastesintheblood.Scrisconsideredasa
markerofalteredglomerularfiltrationrate(GFR)inDN.[21]However,molsidominetreatment
showedasignificantdecreaseinurinevolume,albuminuria,andalsoimprovedtheGFR.
Theseresultsareinaccordancewiththerecentstudyinwhichithadshownthatmolsidomine
hasabeneficialeffectincisplatininducednephrotoxicity.[22]Ontheotherhand,ithasbeen
reportedthatprotectiveeffectofmolsidomineinironinducednephrotoxicityisduetoitsNO
donatingproperty,[10]asNOplayanimportantroleinmaintainingnormalphysiologyof
kidney.

Oxidativestresshasalinkinthepathogenesisofdiabeticcomplications,includingDN.
HyperglycemiainducedactivationofseveralpathwaysresultsintheexcessiveformationROS
thatistoxictothecell.Theyalsointeractwiththelipidbilayerandproducelipidperoxidation
productlikeMDAwhichfurtherdamagesthecells.SOD,CAT,andGSHareresponsiblefor
thedetoxificationoftheROS.[23]Duganetal.[24]revealedthatmitochondrialderived
superoxideanionproductionisreducedindiabetesandplaysapivotalroleinpreservingrenal
functionduringhyperglycemia.Inourstudy,theabilityofmolsidominetoincreaserenal
antioxidantenzymelevelisinlinewiththefindingofChanderandChopra[8]whofoundthat
molsidominerestoredthedepletedrenalantioxidantenzymelevelinischemiareperfusion
renalinjury.Theyalsosuggestedthatthebeneficialantioxidanteffectofmolsidomineisdueto
thedecreasingneutrophilinfiltrationandreducingplasmalevelsofproinflammatory
mediators,whichincreaseoxidativestressandtheseverityofinflammationprocess.Attiaet
al.[25]foundthatNOdeficiencyresultedinpodocytestressinhypercholesterolemicrats,
whilemolsidominepreventedpodocyteinjurysuggestingitsadditionalroleinourstudyforits
nephroprotectiveaction.Thehistopathologyresultsobtainedfromthestudyfurtherconfirmed
ourbiochemicalfindings.Alongwithimprovingrenalfunction,molsidomineprevented
diabetesinducedtubulardegeneration,andglomerulosclerosis.However,furtherresearchis
requiredtoinvestigateitsmolecularmechanismanditscomparativeefficacytotheavailable
treatmentofDN.

Conclusion

Treatmentwithmolsidominepreventedrenaldysfunctiondosedependentlyindiabeticrats.
Nephroprotectiveeffectofmolsidomineisduetoitsantihypertensive,antihyperglycemic,and
antioxidanteffect.MolsidominemaybepromisingasadrugfordelayingandpreventingType
1DNinrats.

FinancialSupportandSponsorship

Nil.

ConflictsofInterest

Therearenoconflictsofinterest.

References

1. ParvingHH,OsterbyR,RitzE.Diabeticnephropathy.In:BrennerBM,editor.The
Kidney.6thed.Philadelphia:WBSaunders2000.p.173173.

2. Tightbloodpressurecontrolandriskofmacrovascularandmicrovascularcomplications
2. Tightbloodpressurecontrolandriskofmacrovascularandmicrovascularcomplications
intype2diabetes:UKPDS38.UKProspectiveDiabetesStudyGroup.BMJ
1998317:70313.
[PUBMED]
3. SzkudelskiT.ThemechanismofalloxanandstreptozotocinactioninBcellsoftherat
pancreas.PhysiolRes200150:53746.
[PUBMED]
4. TeschGH,AllenTJ.Rodentmodelsofstreptozotocininduceddiabeticnephropathy.
Nephrology(Carlton)200712:2616.
[PUBMED]
5. WazWR,VanLiewJB,FeldLG.Nitricoxidemetabolismfollowingunilateralrenal
ischemia/reperfusioninjuryinrats.PediatrNephrol199812:269.
[PUBMED]
6. AraujoM,WelchWJ.Oxidativestressandnitricoxideinkidneyfunction.CurrOpin
NephrolHypertens200615:727.
[PUBMED]
7. IqbalM,OkazakiY,SharmaSD,OkadaS.Nitroglycerin,anitricoxidegenerator
attenuatesferricnitrilotriacetateinducedrenaloxidativestress,hyperproliferative
responseandnecrosisinddYmice.BiochimBiophysActa20031623:98108.
[PUBMED]
8. ChanderV,ChopraK.RenalprotectiveeffectofmolsidomineandLarginineinischemia
reperfusioninducedinjuryinrats.JSurgRes2005128:1329.
[PUBMED]
9. KiranG,NandiniCD,RameshHP,SalimathPV.Progressionofearlyphasediabetic
nephropathyinstreptozotocininduceddiabeticrats:Evaluationofvariouskidneyrelated
parameters.IndianJExpBiol201250:13340.
[PUBMED]
10. GuptaA,SharmaS,ChopraK.Reversalofironinducednephrotoxicityinratsby
molsidomine,anitricoxidedonor.FoodChemToxicol200846:53743.
[PUBMED]
11. NIBPControllerownersguide:ADInstruments,Australia.
www.adinstruments.com/products/manuals/NIBP_Controller_OG.pdf.

12. KurtzTW,GriffinKA,BidaniAK,DavissonRL,HallJ.Recommendationsforblood
pressuremeasurementinexperimentalanimals.Astatementforprofessionalsfromthe
subcommitteeofprofessional&publiceducationoftheAmericanheartassociation
councilonbloodpressureresearch.Circulation2005111:697716.

13. SlaterTF,SawyerBC.Thestimulatoryeffectsofcarbontetrachlorideandother
halogenoalkanesonperoxidativereactionsinratliverfractionsinvitro.Generalfeatures
ofthesystemsused.BiochemJ1971123:80514.
[PUBMED]
14. AebiH.Catalaseinvitro.MethodsEnzymol1984105:1216.
[PUBMED]
15. MoronMS,DepierreJW,MannervikB.Levelsofglutathione,glutathionereductaseand
glutathioneStransferaseactivitiesinratlungandliver.BiochimBiophysActa
1979582:6778.
[PUBMED]
16. MisraHP,FridovichI.Theroleofsuperoxideanionintheautoxidationofepinephrine
andasimpleassayforsuperoxidedismutase.JBiolChem1972247:31705.
[PUBMED]
17. BrowneD,MeekingD,ShawK,CummingsM.Endothelialdysfunctionandpre
symptomaticatherosclerosisintype1diabetesPathogenesisandidentification.BrJ
DiabetesVascDis20033:2734.

18. GuerreroAnalcoJA,HerschMartnezP,PedrazaChaverriJ,NavarreteA,MataR.
AntihyperglycemiceffectofconstituentsfromHintoniastandleyanainstreptozotocin
induceddiabeticrats.PlantaMed200571:1099105.

19. CooperME,GilbertRE,EpsteinM.Pathophysiologyofdiabeticnephropathy.
Metabolism19984712Suppl1:36.

20. YabeNishimuraC.Aldosereductaseinglucosetoxicity:Apotentialtargetforthe
preventionofdiabeticcomplications.PharmacolRev199850:2133.
[PUBMED]

21. FalkRJ,ScheinmanJI,MauerSM,MichaelAF.Polyantigenicexpansionofbasement
membraneconstituentsindiabeticnephropathy.Diabetes198332Suppl2:349.
[PUBMED]
 [PUBMED]
22. KarakocHT,AltintasR,ParlakpinarH,PolatA,SamdanciE,SagirM,etal.Protective
effectsofmolsidomineagainstcisplatininducednephrotoxicity.AdvClinExpMed
201524:58593.
[PUBMED]
23. UgochukwuNH,CobourneMK.Modificationofrenaloxidativestressandlipid
peroxidationinstreptozotocininduceddiabeticratstreatedwithextractsfrom
Gongronemalatifoliumleaves.ClinChimActa2003336:7381.
[PUBMED]
24. DuganLL,YouYH,AliSS,DiamondStanicM,MiyamotoS,DeClevesAE,etal.
AMPKdysregulationpromotesdiabetesrelatedreductionofsuperoxideand
mitochondrialfunction.JClinInvest2013123:488899.
[PUBMED]
25. AttiaDM,FeronO,GoldschmedingR,RadermakersLH,VaziriND,BoerP,etal.
Hypercholesterolemiainratsinducespodocytestressanddecreasesrenalcorticalnitric
oxidesynthesisviaanangiotensinIItype1receptorsensitivemechanism.JAmSoc
Nephrol200415:94957.
[PUBMED]

Figures

[Figure1],[Figure2],[Figure3],[Figure4],[Figure5]


Tables

[Table1]

SiteMap|Home|ContactUs|Feedback|CopyrightandDisclaimer
Onlinesince20thJuly'04
PublishedbyWoltersKluwerMedknow
EditorialandEthicsPolicies

ISSN:Print02537613,Online19983751